NCT03585894View on ClinicalTrials.gov

The Role of Inflammation and Vasodilatation in PACAP38-induced Headache Using MRI on Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

November 25, 2019

Conditions
Headache
Interventions
OTHER

Sumatriptan

Receive intravenous infusion of sumatriptan

OTHER

Ketorolac

Receive intravenous infusion of ketorolac

Trial Locations (1)

2600

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT03585894 - The Role of Inflammation and Vasodilatation in PACAP38-induced Headache Using MRI on Healthy Subjects | Biotech Hunter | Biotech Hunter